Investigation of the immature stage of the cord blood banks and their regulation in China.
Cord blood banks (CBBs) collect umbilical cord blood and isolate therefrom the stem cells which may be transplanted into patients serving treatment of many kinds of serious diseases. As one kind of health resource, CBBs need regulation to guarantee its fair development and safe application. During the past decade, several CBBs have been established in China and related measures have been administered to regulate their establishment and manipulation. How about the actual situation of CBBs in China, including, how are they regulated and what are the problems with the CBBs in practice? Upon introduction to cord blood and the CBBs, this paper investigates the practical situation of the CBBs in China and their regulation, and explores the corresponding problems which need to be dealt with. It is held that the CBB system in China is still at an initial stage, not only for its establishment and operation, but for its regulation as well; and, therefore, justification of a more sustainable CBB system for a better development is needed in China.
Liu
Yinliang
Y
Bio-Law Research Center, China University of Political Science and Law, Beijing, China. yinliangliu@gmail.com
D000328:Adult; D001771:Blood Banks / Q000331:legislation & jurisprudence; D001782:Blood Donors; D002681:China; D036101:Cord Blood Stem Cell Transplantation; D005260:Female; D005312:Fetal Blood; D006412:Hematopoietic Stem Cells; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D017410:Practice Guidelines as Topic; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous